Crowdonomics
All companies
Lightsense Technology logo

Lightsense Technology

Operating

Lightsense Technology, Inc.

Software & AI · Tucson, DE · Founded 2014

Advanced optical pathogen detection to solve critical problems in pubic health

Post-money valuation ⓘ
$18.2M
As of Oct 2022 · from Reg CF Offering (2022) · pre-money + amount raised, not a traded price
Total raised
$2,059,241
Crowd $925K · Private $1.1M · 3 rounds since 2021
Latest share price
$8.57
Reg CF · Preferred Stock · Jul 2022 offering price

Financials

FY2019–FY2023 · from SEC filings · hover any figure for its source
$0
−$199K
2019
2020
$26K
−$70K
2021
$89K
−$344K
2022
$70K
−$1.0M
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019 reviewed
FY2020 reviewed
FY2021 audited*
FY2022
FY2023
Income statement
Revenue
$0
—
$25,949
$88,747
$69,500
Cost of goods sold
$0
—
$2,040
$1,040
$4,596
Gross margin
—
—
92%
99%
93%
Net income
-$199,495
—
-$69,896
-$343,533
-$1,005,797
Taxes paid
$0
—
$0
$0
$0
Balance sheet
Cash
$71,367
—
$24,969
$803,310
$474,821
Accounts receivable
$0
—
$16,549
$0
$10,261
Total assets
$71,367
—
$50,850
$910,771
$836,467
Short-term debt
$125,034
—
$517,279
$51,411
$16,253
Long-term debt
$344,832
—
$0
$569,382
$0
Total liabilities
$469,866
—
$517,279
$620,793
$16,253
Other
Headcount
—
5
11
10
10

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$12.0M
pre-money
$18.0M
pre-money
Reg CF · Preferred · Oct 2021
Reg CF · Preferred · Jul 2022

Blue bars are the pre-money valuation the company stated for a priced round.

Share price over rounds

$8.57$4.285$7.0822
Oct 2021Jul 2022
Round offering price or verified disclosed saleDisclosed sale, unverified or year-only

Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.

Fundraising history

Raised $180.4K / $2MInvestors 57Post-money $18.2M
Raised $744.4K / $1.1MPost-money $13.8M

Team

11 people
Terje Skotheim, Ph.D.
CHIEF EXECUTIVE OFFICER

Terje is a world-renowned scientist in physics and materials science. For more than 25 years, after a successful academic career, Terje has focused on bringing technologies from the laboratory to the product stage, including advanced MEMS technology, spectrometers & sensors, lithium batteries, biosensors, and high-power lasers. Terje is part of 70 patents, 5 patent applications, and more than 200 publications. He is a founder of several start-up companies. He holds a B.S. in Physics from MIT and a Ph.D. in Physics from UC Berkeley.

Bruce Berkoff
CHIEF MARKETING OFFICER

Bruce has a long history and wealth of global experience in the technology industry, having held key marketing (CMO) positions at several leading technology companies. Bruce is currently an Advisor/Mentor at SkyDeck Berkeley, EIR at Vonzos Partners, Chairman of the LCD TV Association, and a frequent advisor to various startups. He was also CMO at CBRITE, CMO/CSO at Applied Materials (AMA T)/AKT, and EVP CMO at LG Philips LCD, and others. Bruce holds undergraduate and graduate degrees in Physics and Biophysics from Princeton and UC Berkeley, respectively. He has been on the BoD of 5 public companies, including LG Display.

Wade Poteet, Ph.D.
CHIEF TECHNOLOGY OFFICER

With more than 30 years experience as a research physicist/engineer, Wade has emphasized system design and manufacturing of advanced instrumentation in optics, electro-optics, and detector technology from X-rays to the far infrared spectrum, including ultra-high precision devices and large telescopes. He has received recognition awards from NASA and has a B.S. and Ph.D. in Physics from the Virginia Polytechnic Institute.

Gordon Davidson
VP Government Programs

Gordon is overseeing Lightsense activities directed at the federal government. Gordon comes from a long and successful career in Federal Government agencies. Gordon was a Director at EPA and advisor to DOE under Clinton and has subsequently been advising a number of early stage companies, with a focus on energy and environment. Gordon is a graduate of Duke University.

John Coates, Ph.D.
VP Optical Design

John is a veteran of the optics and spectroscopy industry with a storied career, including at Perkin-Elmer & Nicolet, with over 30 years of experience in optical spectroscopy, instrumentation & sensor design. John has been responsible for developing over 90 spectroscopy systems with a focus on miniaturization and has made key contributions to the Lightsense spectrometer products.

Joshua Nelson
VP Finance

Josh provides financial and organizational leadership in Lightsense, including ongoing financial management, financial & tax strategy, and risk management strategy. He plays a key role in organizing the manufacturing supply chain for Lightsense spectrometers. Previously, he has provided financial leadership for multinationals (Mettler-Toledo Process Analytics) and Tucson-based startups (Sion Power Corporation, Instant Bioscan). Josh has a B.S. in Business Administration from the University of Arizona.

Kevin Harris
VP Engineering

Kevin has over 20 years of experience, including managing large programs in engineering design of optical systems and instruments, including extensive work on telescopes and space optical platforms. Kevin has extensive experience in writing software using all major protocols of electronic communication. Earlier in his career, Kevin was a Sr. Electronics and Electrical Engineer at the University of Arizona Optical Sciences. Kevin is responsible for the electronic design and data acquisition and control.

Michael Berman
VP Manufacturing

Mike has 30 years' experience in microchip and MEMS development and manufacturing in the US and Asia, covering chip design, process and equipment engineering, maintenance, and production. Mike has been responsible for engineering and R&D at Advanced Micro Devices, LSI Logic and Sematech, and has over 50 patents in chip processing technology. He has played leadership roles in building manufacturing plants from Texas to Malaysia. Mike oversees manufacturing of the current Lightsense drug detection products and the manufacturing supply chain.

Michael Stanley
VP Machine Learning

Mike oversees the critically important machine learning and cloud database design, a core element in the Lightsense spectroscopy system design. His career spans three decades at Motorola Semiconductor, Freescale Semiconductor, and NXP Semiconductor, where he led efforts in machine learning development for the Sensor Division. He is a Senior Member of the IEEE, a contributor to the IEEE Standard for Sensor Performance Parameter Definitions (IEEE Std 2700TM-2014) as well as the 2nd edition of the Measurements, Instrumentation, and Sensors Handbook by CRC Press. He was inducted into the MEMS & Sensors Industry Group Hall of Fame in 2015 and he is an active member of the Industry Advisory Board for the NSF-funded Sensor, Signal, and Information Processing Center (SenSlP) at Arizona State University.

Show 2 more people
Richard Kris Ph.D
VP Biotechnology

Rick oversees application to non-invasive biomedical diagnostics and is coordinating collaborative work with academic research laboratories. Rick studied virology, concentrating on Influenza virus infection and has a long career (over 30 years) in diagnostics and biomedical technology, having served on the faculty of NYU School of Medicine before joining the biotech industry, first as a senior scientist at Selectide, a drug discovery company, before becoming a founder/partner in Nuvogen Research, a successful drug discovery startup.

Stephen Whalley
Board Director

Steve’s career includes 25 years with Intel Corporation in pan-European and US functions directing multiple product and technology development programs. He has led and served on multiple industry association boards in the semiconductor and MEMS/sensors arenas impacting numerous successful technology developments such as USB, PCI and others.

Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 2 of 5 annual reports (FY2021–FY2025)

57 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARApr 28, 20230001873409-23-000001
    EDGAR
  • Form CJul 12, 20220001665160-22-002009
    EDGAR
  • Form C-UJun 6, 20220001665160-22-001757
    EDGAR
  • Form C-ARMay 3, 20220001805637-22-000003
    EDGAR
  • Form C-UJan 19, 20220001788590-22-000002
    EDGAR
  • Form COct 28, 20210001788590-21-000002
    EDGAR
Source: ManualCIK 0001873409DEShare price $8.57

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.